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Abstract
The current study tested the Integral Model of treatment motivation (IM) in a sample of 294 outpatients with severe mental 
illness, using structural equation modelling. The obtained structural model was not consistent with original theory, nor was 
the model invariant across time and patient groups (psychotic disorders and personality disorders). The patient’s perceived 
suitability of treatment, perceived costs of treatment and outcome expectancy were most strongly associated with motiva-
tion and treatment engagement. The model explained between 22 and 86% of variance in clinical outcomes, depending on 
the timing of the assessment. Currently, the IM does not constitute a robust framework for patterns through which patients 
become motivated to engage in treatment, but does explain substantial amounts of variance in clinical outcomes. The future 
potential of IM as a basis for interventions in the mental health care is discussed, including suggestions for subsequent 
research and potential alterations of the IM to improve its utility for application in clinical practice.
Keywords Motivation · Theory · Structural equation model · Psychotic disorders · Personality disorders
Introduction
Background and rationale
The Integral Model of treatment motivation (IM) is a health 
behavior theory that was specifically developed for appli-
cation in mental health treatment to understand patients’ 
motivation for engaging in treatment (Drieschner et  al. 
2004). The IM holds that six cognitive and emotional fac-
tors, called internal determinants (Drieschner et al. 2004), 
predict the patient’s motivation for engaging in treatment 
(MET). The patient’s motivation is seen as the mediator 
between the internal determinants and actual treatment 
engagement. The Treatment Motivation Scales for forensic 
outpatient treatment (TMS-f) was developed by the found-
ers of IM to assess the constructs in the theory (Drieschner 
and Boomsma 2008a). A series of studies using the TMS-f 
in a forensic psychiatric setting showed support for its 
hypothesized factorial structure and showed adequate reli-
ability and validity(Drieschner and Boomsma 2008a, b). The 
studies also found support for the general tenets of the IM, 
such that three out of six internal determinants were indeed 
statistically significantly related to the patient’s motivation 
for engaging in treatment, which in turn was predictive of 
treatment engagement (Drieschner and Boomsma 2008a, b; 
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Drieschner and Verschuur 2010). However, the relationships 
between the core constructs of the IM are in need for further 
empirical testing, including the plausibility and utility of the 
model outside a forensic psychiatric population. Therefore, 
the current study aimed to test the IM in a sample of Dutch 
adult outpatients with severe mental illness using a slightly 
adapted version of the TMS-f. The following describes the 
general tenets of IM, previous research findings and our 
study objectives.
The Integral Model of treatment motivation
The IM is theoretically affiliated with Ajzen and Fishbein’s 
theory of planned behaviour (Ajzen 1991), with a strong 
focus on attitudes toward the behaviour, subjective norms, 
and perceived behavioural control. The theory of planned 
behaviour however, does not account for other factors that 
can influence motivation, such as distress, past experience 
or environmental factors, which are relevant in the context 
of motivation for engaging in treatment (-related behaviours) 
(Drieschner et al. 2004). The IM does take into account 
these factors more explicitly and may therefore be more 
useful in the context of mental health care. The IM holds 
that the patients’ MET depends on the six internal determi-
nants (IDs), which in turn are determined by external factors 
such as treatment characteristics, external circumstances, 
life events, demographic features and the type of problem. 
These external factors are thought to have their effect on 
motivation only through the IDs (Drieschner et al. 2004). 
The IDs comprise problem recognition, distress, perceived 
costs of the treatment, perceived suitability of the treatment, 
outcome expectancy and perceived legal pressure. Problem 
recognition refers to the recognition that one has a prob-
lem, the willingness to admit to the presence of a problem 
and the recognition that one must change to prevent recidi-
vism. Distress is the level of suffering that might result from 
symptoms, social problems or having fear of deterioration in 
any area of life. Perceived costs of the treatment are the fee 
and the time the patient feels is spent on treatment, and the 
psychological costs resulting from exposure to unpleasant 
emotions and changes in lifestyle. Perceived suitability of 
the treatment encompasses three facets: the patient’s per-
ception of appropriateness and effectiveness of the therapy, 
the patients’ agreement with the goals of treatment and the 
patients’ perception of the therapeutic relationship. Outcome 
expectancy refers to the patient’s expectancy of being able to 
finish the treatment, have success and believe in the ability 
to change. Finally, perceived legal pressure is the patient’s 
perception of the external pressure through the legal system. 
As the current study will explore whether the IM is also 
applicable outside a forensic psychiatric setting, the cur-
rent study decided to adapt the construct of perceived legal 
pressure into a more broad perceived external pressure by 
others. This adjustment can be justified by considering that 
only a subgroup of outpatients with SMI will be referred 
to or pressured into psychiatric treatment via the legal sys-
tem, while (most) others will likely experience other pres-
sures that drive their motivation for engaging with treat-
ment (i.e. family, friends, partner, assertive outreaching 
clinicians). For clarity, we will refer to the revised scale as 
the TMS-p instead of the TMS-f, to indicate that the revised 
scale may be applied in a general psychiatric (hence the “p”) 
population.
Further, MET is thought to predict treatment engagement, 
which in turn is a predictor of treatment outcome. However, 
the relationship between MET and treatment engagement is 
not presumed perfect, because of the possibility that patients 
may lack the capacity to do what the treatment requires due 
to cognitive, neuropsychological and other limitations (Dri-
eschner et al. 2004). Also, treatment outcome may depend 
on the effectiveness of the treatment approach and the per-
sistence of the patients’ problems (Drieschner et al. 2004; 
Drieschner and Verschuur 2010) which may result in only 
a modest relationship between treatment engagement and 
treatment outcome.
In a previous empirical study on the IM by Drieschner 
and Boomsma (2008b), the model was mostly supported 
but not all findings were in line with original hypotheses. 
For example, treatment engagement was best predicted by 
MET and by the patient’s perceived suitability of treatment, 
while distress and perceived legal pressure were found vir-
tually unrelated to MET and treatment engagement (Dri-
eschner and Boomsma 2008b). Also, perceived suitability 
of treatment was found to predict treatment engagement 
directly, beyond the mediated effect of MET (Drieschner and 
Boomsma 2008b). Figure 1 shows the IM as applied to the 
current study, which is similar to the originally hypothesized 
model by Drieschner et al. (2004) but includes additional 
clinical outcomes and perceived external pressure as one 
of six IDs as opposed to perceived legal pressure. These 
outcomes were added to evaluate the clinical utility of the 
model in outpatients with SMI.
The use of scales of measurement requires that they are 
able to measure the same construct in different populations 
and at different times, which is called invariance across 
populations and across time, respectively (Bontempo et al. 
2011). That is, although patients may change in their respec-
tive levels of motivation and outcome expectancy and per-
ceived external pressure over time, the associations between 
the constructs in the theoretical model should remain con-
stant across different patient populations and time. To evalu-
ate a motivation theory such as the IM, we argued that a 
good theory is invariant across populations and across time, 
such that the theory allows to explain clinical outcomes. 
Therefore, the current study aimed to test the invariance of 
IM across time and across patient diagnostic groups, and it 
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was tested whether the model could explain variance in the 
clinical outcomes psychosocial functioning and quality of 
life. Specifically, the objectives for the current study were 
as follows:
Objectives
1. It was tested whether the IM-model as outlined in Fig. 1 
was plausible. We hypothesized that the model in Fig. 1 
would show good fit to the data, and if not, we would 
test which alternative model was most plausible.
2. It was tested whether the most plausible model could 
be considered invariant across time (i.e. baseline and 
one year later) and across patient groups (i.e. patients 
with primarily a personality disorder versus those with 
primarily a psychotic disorder).
3. The clinical utility of the model was evaluated by 
investigating to which extent the IM model explained 
observed variance in the clinical outcomes of psycho-
social functioning and quality of life.
Methods
Study design
The current longitudinal study constitutes a secondary anal-
ysis of a cluster randomized clinical trial (Jochems et al. 
2012). The design of this trial and the intention-to-treat 
analyses were reported elsewhere (Jochems et al. 2012). The 
current study was approved by the Medical Ethical Commit-
tee for Mental Health Care Institutions (Dutch Trial Registry 
NTR2968) as well as by the scientific committees of the 
two specialty mental health institutions where the data were 
collected.
Setting
Data were collected from 12 outpatient treatment programs, 
including a forensic psychiatric outpatient clinic, three spe-
cialized psychotic outpatient treatment programs and eight 
function-assertive community treatment teams [FACT-teams 
(van Veldhuizen 2007)] of two Dutch treatment centres: 
GGZ Westelijk Noord Brabant and GGz Breburg. FACT-
teams provide assertive, outreaching, community-based, and 
supportive psychiatric services to individuals with SMI (van 
Veldhuizen 2007), such as those with psychotic disorders 
and severe personality disorders.
Participants and procedures
Inclusion criteria for patients were: a primary diagnosis of 
psychotic or personality disorder, aged 18 to 65 years, under-
going individual outpatient treatment and having a sufficient 
command of the Dutch language. A clinician was eligible 
for participation if he or she was the primary health care 
provider involved with the patient and saw the patient most 
frequently. Eligible patients on the clinicians’ caseload lists 
were approached and informed by researchers and asked for 
their signed consent. Both patients and clinicians were asked 
to fill in questionnaires at baseline and follow-up assess-
ment (12 months after baseline) and additionally, patients 
were interviewed regarding their functioning in several life 
domains by independent research assistants at these assess-
ment moments. To enhance the likelihood of participation, 
patients were given an incentive of 15 euro for the baseline 
and follow-up assessment in the trial.
Measures
Core theoretical constructs of IM: internal determinants 
and motivation for engaging in treatment
Treatment motivation and the six internal determinants were 
measured by a revised version of the Treatment Motivation 
Scales for Forensic patients (TMS-f), which we will refer 
to as the TMS-p. In the TMS-p, the subscale of perceived 
legal pressure from the TMS-f was adapted to represent a 
broader perceived external pressure by others. For example, 
where in the original TMS-f an item is ‘I feel a strong pres-
sure from the legal system’, this was substituted for ‘I feel a 
Fig. 1  Hypothesized process model for IM. Note The figure depicts 
latent variables, the observed variables and accompanying measure-
ment errors underlying the latent variables were left out to avoid a 
cluttered presentation
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strong pressure from others’. The entire modified scale and 
additional psychometric properties of the adapted subscale 
can be found in the online supplementary material. Besides 
the changes to the perceived legal pressure scale, no other 
changes were made to the original TMS-f. The items were 
rated on a 5-point Likert scale (0 = totally agree to 5 = totally 
disagree). The subscale scores were calculated in such a 
way that a higher score on the subscale represented higher 
perception of that respective scale, including the subscale 
perceived costs of the treatment (i.e. higher scores repre-
sented higher perceived costs of the treatment). The con-
generic estimates of reliability for the seven subscales of 
the TMS-p for the baseline and follow-up assessment in the 
current study were as follows: problem recognition = 0.80 
and 0.80, distress = 0.90 and 0.91, external pressure = 0.61 
and 0.68, costs of treatment = 0.77 and 0.79, suitability of 
treatment = 0.86 and 0.89, outcome expectancy = 0.86 and 
0.85, and motivation for engaging in treatment = 0.82 and 
0.86, respectively. The TMS-f was found to be a reliable 
and valid operationalisation of the constructs in the Integral 
Model in previous studies (Drieschner and Boomsma 2008a, 
b). In a previous study in outpatients with severe mental 
illness, we found statistically significant low to moderate 
correlations between the motivation subscale of the TMS-p 
and motivation scales derived from other motivation theories 
(Jochems et al. 2014).
Clinical outcomes: treatment engagement, psychosocial 
functioning and quality of life
Treatment engagement was measured with the service 
engagement scale (SES) that was filled out by clinicians. 
The SES was developed to measure engagement with com-
munity mental health services (Tait et al. 2002). It comprises 
14 items that assess availability, collaboration, help seeking 
and treatment engagement behaviours, including medication 
adherence. The items are rated on a 4-point scale ranging 
from 0 (not at all) to 3 (most of the time). The SES has 
good internal consistency (Cronbach’s α = 0.87, congeneric 
estimate of reliability = 0.91 in the current patient sample) 
and validity is supported by discrimination between criterion 
groups (Tait et al. 2002) and significant associations with 
therapeutic alliance and motivation for engaging in treatment 
(Jochems et al. 2014). The SES total scale score was used 
as the outcome measure in this study, where higher scores 
denote higher treatment engagement.
The patient’s psychosocial functioning was measured 
with the Dutch version of the Health of the Nations Outcome 
Scales (HoNOS)(Mulder et al. 2004; Wing et al. 1998). The 
HoNOS is a semi-structured interview with the patient in 
which health and social problems of the previous 2 weeks 
are quantified. It contains 12 items that refer to behavioural 
problems, cognitive and physical impairments, symptoms, 
and social functioning. HoNOS items are scored on a scale 
from 0 (no problem) to 4 (severe problem). The total scale 
score is computed by adding the 12 items. For ease of inter-
pretation, we reversed the total score such that higher scores 
reflected higher levels of psychosocial functioning. The 
administration of the HoNOS was performed by independ-
ent research assistants (mostly graduate students in psychol-
ogy and medicine) who had no involvement in the patient’s 
treatment. Patients were interviewed at the team office or 
at home, depending on their preference. The psychometric 
properties of the total scale score were shown to be accept-
able and sensitive to change (Wing et al. 1998). Internal 
consistency was acceptable in the current study (Cronbach’s 
α = 0.70, congeneric estimate of reliability = 0.77).
The patient’s quality of life was assessed with the Man-
chester Short Assessment of Quality of Life (MANSA) 
(Bjorkman and Svensson 2005; Priebe et al. 1999). The 
MANSA is a self-report questionnaire that asks the patient 
how satisfied he/she is in the following life domains: liv-
ing situation, social relationships, physical health, mental 
health, safety, financial situation, work situation and life as 
a whole. The 12 items are scored on a Likert scale from 
1 (couldn’t be worse) to 7 (couldn’t be better), which are 
summed to calculate a total score. Higher scores denote a 
higher perceived quality of life. The scale is shown to be 
reliable (i.e. Cronbach’s α = 0.82 and congeneric estimate 
of reliability = 0.92 in the current patient sample) and other 
psychometric properties are considered satisfactory (Priebe 
et al. 1999).
Socio‑demographic factors and clinical diagnosis
The DSM-IV diagnosis as made by the psychiatrist of the 
team was obtained from the patients’ medical record, as well 
as socio-demographic data such as gender, age, ethnicity, 
age of onset and legal status. If these data were missing in 
the medical record, the patient was asked to provide this 
information.
Statistical analyses
The analyses were performed in several steps. First, the 
bivariate relations of variables were estimated using Spear-
man correlations. Structural equation modelling (SEM) as 
implemented in Mplus version 7.3 (Muthén and Muthén, 
1998–2012) was used to test the hypothesized relationships 
between autonomy support, perceived competence, types of 
motivation, treatment engagement, psychosocial functioning 
and quality of life as depicted in Fig. 1.
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Latent variables
Both at baseline and at follow-up we evaluated the plau-
sibility of the IM-model using latent path analysis as out-
lined in Fig. 1. We first estimated the congeneric reliabili-
ties (Jöreskog 1971; Reuterberg and Gustafsson 1992) by 
applying confirmatory factor analyses to the observed items 
of the following four questionnaires individually: TMS-p, 
SES, HoNOS and MANSA. Then, the latent constructs for 
each of these four questionnaires were estimated by a factor 
analysis model in which the factor loading was fixed at 1.0 
and the residual variance of that factor (i.e. 1-congeneric 
estimate of reliability) was multiplied by the variance of the 
variable at issue. Hence, the analyses consisted of two steps: 
(1) observed items of each of the four questionnaires were 
first added to create total scale scores, (2) then, for each of 
the four questionnaires, the latent constructs were estimated 
by correcting the observed total scale scores for unreliability. 
The latent constructs were used in model testing.
Testing the invariance of the structural model
As the type of design was complex (patients clustered within 
teams) and, in addition, the distributions of the variables 
were considered to be non-normal, the estimation method 
used was MLR. This maximum likelihood estimates stand-
ard errors and χ2 test statistic that are robust to non-nor-
mality and non-independence of observations. The MLR 
standard errors were estimated using a sandwich estimator. 
Additionally, the variable ‘team’ was included as an addi-
tional level in the analyses to adjust for potential clustering 
of the data within the 12 treatment teams.
First, the model as depicted in Fig. 1 was fitted to the 
data for the full sample using the baseline and follow-up 
measurements separately. The following measures were 
used to test for adequacy of the model fit: χ2 for model fit 
(low and non-significant values of the χ2 were desired; P 
value > 0.05); χ2/df ratio (a value < 2.0 was considered to 
be acceptable); information criteria including Akaike (AIC), 
Bayesian (BIC), sample-size adjusted BIC (SS-BIC) (the 
smaller the better); comparative fit index (CFI), and Tucker-
Lewis Index (TLI) [high values are desired (> 0.95), val-
ues > 1.0 point to over identification (Bentler 1990; Tucker 
and Lewis 1973)]; Root Mean Square Error of Approxima-
tion (RMSEA): a value < 0.05 indicates a close fit (Browne 
and Cudeck 1992); and Standardized Root Mean Squares 
of Residuals (SRMR: a value of < 0.05 indicates a reliable 
fit) (Hu and Bentler 1999). Explained variances (R2) were 
used to describe the performances of the determinants for 
the individual dependent variables.
It was tested whether the baseline model showed a good 
overall fit. If not, it was evaluated how it could be adapted 
such that the fit would improve or alternatively, whether the 
model could be simplified while not threatening the over-
all model fit. The most plausible model was obtained by 
evaluating the model fit criteria and standardized residuals. 
Further, the MLR χ2 difference test was used to compare 
different models which were nested. The χ2 difference was 
based on log-likelihood values and scaling correction fac-
tors obtained with the MLR estimator, using the formula 
Δχ2= − 2* (L0 − L1)/cd where L0 is the log likelihood of 
the constrained (nested) model, L1 is the log likelihood of 
the unconstrained model and cd is the difference test scal-
ing correction (which is based on scaling correction factors 
(c0 and c1) and number of parameters (p0 and p1) for the 
constrained and unconstrained models, respectively).
The invariance of the most plausible path model across 
time was evaluated by testing the invariance of the regres-
sion estimates of the latent variables, by comparing those 
assessed at baseline with those assessed at follow-up using 
the MLR χ2 difference test. Fitting both latent path models 
(baseline and follow-up) jointly was used to test whether the 
regression estimates of both time points could be considered 
invariant. Specifically, a non-significant MLR χ2 difference 
test between the model with all regression estimates con-
strained to be equal for the corresponding measurements 
versus all regression estimates unconstrained was considered 
statistical evidence for the latent path model being invariant 
across time. Individual estimates were regarded statistically 
significant if the two-sided P values were < 0.05. The cor-
relations of the latent variables between the corresponding 
measurements were allowed to be free as the measurements 
were repeated. The next step was to test the invariance of 
the model across different patient groups (personality dis-
orders versus psychotic disorders). This was done according 
to the same procedure used in testing invariance across time, 
where the MLR χ2 difference test was used to test equality 
constraints between nested models.
Explained variance of clinical outcomes
To test to what extent the obtained IM- model has utility for 
clinical practice, it was evaluated how much variance was 
explained on the dependent variables in the model, including 
treatment engagement, psychosocial functioning and quality 
of life.
Results
Participants and descriptive data
A total of 294 patients and 57 clinicians were included 
between May 2011 and September 2012. Patient character-
istics are shown in Table 1. The majority of patients with 
psychotic disorders were diagnosed with schizophrenia 
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(48%), schizoaffective disorder (16%), or psychotic disorder 
not otherwise specified (24%). In the group with primar-
ily personality disorders, 40% had a borderline personality 
disorder, 13% had antisocial personality disorder, and 26% 
had a personality disorder not otherwise specified. Most 
clinicians were female (63%), their mean age was 44 years 
(SD = 10.70) and they had a mean of 16 years of clinical 
working experience in mental health services (SD = 9.30). 
Potentially relevant differences between our study sample 
and the forensic psychiatric samples studied by Drieschner 
and Boomsma (2008a, b) include that their sample had a 
higher percentage of males (around 90%), higher percent-
age of legal mandates for treatment (around 53%), and less 
patients with psychotic disorders (around 9%).
Table 1  Baseline characteristics of participating patients, stratified by primary diagnosis
SD standard deviation, min to max minimum value to maximum value on the scale, IQR interquartile range
a The definition of Dutch Ethnicity was based on the definition by the Dutch Bureau of Statistics
b Substance abuse problem was defined as having a DSM-IV diagnosis of substance abuse and/or dependence in the medical record
Total patient sample
N = 294
Psychotic disorders
n = 199
Personality disorders
n = 95
Age, mean (SD) 44 (10.3) 43 (10.3) 45 (10.0)
Male gender, n (%) 179 (60.9) 132 (66.3) 47 (49.5)
Dutch  ethnicitya, n (%) 208 (70.7) 140 (70.4) 68 (71.6)
Education level, n (%)
 No education/elementary 108 (36.7) 76 (38.2) 32 (33.7)
 Secondary school 124 (42.2) 75 (37.7) 49 (51.6)
 Upper high school and over 59 (20.1) 47 (23.6) 12 (12.6)
Comorbid substance use  problemsb, n (% yes) 74 (25.2) 42 (21.1) 32 (33.7)
Legal mandate, n (% yes) 24 (6.9) 13 (6.5) 11 (12.0)
One or more previous admissions, n, (% yes) 227 (77.2) 159 (79.9) 68 (71.6)
Problem recognition
 Mean (SD) 30.2 (7.7) 28.6 (7.7) 33.75 (6.7)
 Min to max (range) 10 to 45 (35) 10 to 45 (35) 16 to 45 (29)
Distress
 Mean (SD) 25.7 (9.6) 23.6 (9.1) 33.8 (6.7)
 Min to max (range) 9 to 45 (36) 9 to 45 (36) 12 to 45 (33)
External pressure
 Mean (SD) 30.4 (5.9) 30.2 (6.0) 30.0 (9.2)
 Min to max (range) 11 to 45 (34) 11 to 45 (34) 18 to 42 (24)
Perceived costs of treatment
 Mean (SD) 19.9 (6.9) 19.8 (7.1) 30.9 (5.8)
 Min to max (range) 9 to 43 (34) 9 to 43 (34) 9 to 37 (28)
Suitability of treatment
 Mean (SD) 35.0 (7.2) 35.1 (7.3) 20.3 (6.4)
 Min to max (range) 12 to 45 (33) 14 to 45 (31) 12 to 45 (33)
Outcome expectancy
 Mean (SD) 31.9 (8.1) 32.5 (8.2) 34.7 (7.0)
 Min to max (range) 12 to 45 (33) 12 to 45 (33) 13 to 45 (32)
Motivation to engage in treatment
 Mean (SD) 47.2 (11.7) 47.4 (11.7) 46.9 (12.0)
 Min to max (range) 16 to 80 (64) 18 to 80 (62) 16 to 78 (62)
Treatment engagement
 Median (IQR) 31 (24 to 36) 32 (25 to 37) 28 (24 to 35)
Psychosocial functioning
 Median (IQR) 9 (6 to 13) 8 (5 to 12) 10 (8 to 15)
Quality of life
 Median (IQR) 5 (4 to 5) 5 (4 to 5) 4 (4 to 5)
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After 12 months, 253 patients (86%) were re-assessed. 
The group that was lost to follow-up was significantly more 
often of non-Dutch ethnicity (48% versus 26%, P < 0.01) and 
more often had a legal mandate for treatment (18% vs. 7%, 
P = 0.03) compared to completers.
Table 2 shows Spearman correlations between variables 
that were included in the IM model. MET was most strongly 
correlated with the subscales perceived costs of treatment, 
suitability of treatment and outcome expectancy. The cor-
relation between motivation for treatment with treatment 
engagement was moderate for both time points (r = .28 and 
r = .30, respectively). Further descriptive statistics of the 
TMS-p scales, including results from confirmatory factor 
analyses on each subscale and on the model including the 
six IDs as predictors for motivation, are presented in the sup-
plementary material online. Based on these analyses, it was 
decided that the TMS-p was suitable for subsequent analyses 
in the current study.
Path analysis
Establishing a plausible structural model
First, all observed variables were linearly transformed 
by a factor of 10 to reduce their variances which allowed 
Mplus to reach convergence. The observed variables were 
then corrected for unreliability resulting in the latent vari-
ables, which were used in the subsequent path analyses. 
Table 3 shows the model fit information of the models that 
were subjected to latent path analyses. The IM- model as 
depicted in Fig. 1 was fitted to the data at baseline (Model 
1a) and at follow-up (Model 2a). Model 1a provided a bad 
fit to the data (χ2/df = 8.30, RMSEA = 0.16, CFI = 0.88, 
TLI = 0.71, SRMR = 0.13) and Model 2a provided a border-
line fit (χ2/df = 3.94, RMSEA = 0.10, CFI = 0.95, TLI = 0.86, 
SRMR = 0.09).
In search of a more plausible model, modification indi-
ces and, in particular, standardized residuals were inspected. 
These did not provide theoretically plausible nor unequivo-
cal suggestions for improving model fit. That is, the indices 
pointed to several lacking direct effects between internal 
determinants and clinical outcomes (treatment engagement, 
psychosocial functioning and quality of life), some of which 
were opposite to theoretical expectations. Therefore, it was 
decided to investigate whether the structural model that was 
empirically obtained by Drieschner and Boomsma (2008b) 
would show better fit to the data than the originally hypoth-
esized model (2004).
The empirically derived model by Drieschner and 
Boomsma (2008b) was tested at both time points and 
labelled as model 1b (baseline) and model 2b (follow-up) in 
Table 3. This model is shown in Fig. 2 and included indirect 
paths from problem recognition, outcome expectancy and 
costs of treatment to treatment engagement via MET (while 
the paths between the remaining three internal determinants 
and MET were constrained to 0), and direct paths from suit-
ability of treatment, external pressure and MET to treatment 
engagement. As model fit was not good, modification indi-
ces and standardized residuals were inspected. These sug-
gested that there should be direct paths from suitability of 
treatment and external pressure to psychosocial functioning 
and quality of life, as shown by the dotted lines in Fig. 2 
(models 1c and 2c). The results in Table 3 show that model 
fit improved slightly but remained borderline for baseline 
assessment (models 1b and 1c), whereas it became worse 
for the follow-up assessment (models 2b and 2c) compared 
to the model depicted in Fig. 1. Thus, these models did not 
show acceptable fit to the data.
In search for a more plausible model, a model was tested 
which included paths from all predictors to all subsequent 
variables in the model (i.e. resulting in 0 degrees of free-
dom). By definition, the fit of this model (which we labelled 
‘saturated-model’) was perfect for both assessment moments 
(see models 1d and 2d in Table 3). Subsequently, a backward 
elimination procedure was applied to the saturated-model 
to obtain a more constrained model while not statistically 
significantly reducing model fit. The MLR χ2 difference 
test was used to compare nested rivalling models on model 
fit. The backward procedure started with the constriction of 
paths from the internal determinants to the distal outcomes 
(psychosocial functioning and quality of life) as these paths 
were least in line with theory (Drieschner et al. 2004). Spe-
cifically, the regression paths were sequentially constrained 
to zero between each internal determinant and the two distal 
outcomes to determine which constrictions were acceptable, 
i.e. did not statistically significantly reduce model fit. It was 
found that all paths between the internal determinants and 
two distal outcomes could be constrained to zero except for 
the path between distress and both outcomes. The fit for this 
model for both assessment moments is presented in Table 3 
(models 1e and 2e) and also shows the results of the MLR χ2 
difference test between the saturated-model (models 1d and 
2d) and the constrained models (models 1e and 2e).
Subsequently, it was investigated if the path from MET to 
the distal outcomes could be constrained to zero, which was 
acceptable for the baseline model but not for the follow-up 
assessment. It was therefore decided to retain this path in 
the model unconstrained. Then, it was investigated which 
paths between the internal determinants to treatment engage-
ment could be constrained to zero without significant loss of 
model fit. It was found that all paths from internal determi-
nants to treatment engagement could be constrained to zero, 
except for the paths from distress and external pressure to 
treatment engagement (see Table 3 for the MLR χ2 differ-
ence test between the saturated-model and models 1f and 
2f). This model was accepted as the final model, as further 
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constrictions (e.g. between the IDs and MET) would hinder 
the testing of the ‘core’ of the original theory which consists 
of the mediating role of motivation between the six internal 
determinants and treatment engagement (Drieschner et al. 
2004). Figure 3 shows the accepted final structural model 
including the standardized regression coefficients for all 
paths in the model, in which it can be seen that the strongest 
positive associations were found from perceived suitabil-
ity of treatment, perceived costs of treatment and outcome 
expectancy to motivation for engaging in treatment, whereas 
strong negative associations were found between distress and 
treatment engagement, psychosocial functioning and quality 
of life.
Test of the IM process model across time and across patient 
groups
Subsequently, the best-fitting model (1f/2f) was tested across 
time and across patient groups. Testing the obtained pro-
cess model across time was done by testing the invariance 
of the regression estimates of the latent variables across 
the two measurement occasions. A model was created in 
which both baseline and follow-up latent path models 
were included simultaneously (Model 3). In the first ver-
sion of this model the regression weights were allowed 
to be free (unconstrained) for the baseline and follow-up 
measurements (Model 3a), which resulted in borderline 
fit to the data (χ2/df = 2.85, RMSEA = 0.08, CFI = 0.94, 
TLI = 0.86, SRMR = 0.08). Then, a second version of this 
model was created in which the regression weights for the 
corresponding paths at baseline and follow-up were con-
strained to be similar (Model 3b). Compared to Model 3a, 
Model 3b provided much worse fit to the data (χ2/df = 5.84, 
RMSEA = 0.13, CFI = 0.80, TLI = 0.63, SRMR = 0.17). The 
test for invariance across time was represented by the MLR 
χ2 difference test between Models 3a and 3b, where a non-
significant χ2-test was considered statistical evidence for 
the latent path model being invariant across time. As can be 
seen in Table 4, the χ2-test reached statistical significance 
(Δχ2 = 247.47, Δdf = 15, P = < 0.01), implying that the IM 
model was not invariant across time. That is, the regres-
sion coefficients between variables in the model could not 
be considered similar for the baseline and follow-up assess-
ments, as at least some of these were significantly different 
for the two time points. Model 3a is shown in Fig. 2, includ-
ing standardized regression coefficients for the baseline and 
follow-up measurements.
Additionally, it was tested whether the IM model was 
invariant across different patient groups. To this end, the 
IM model was tested for differences between the group 
of patients with a primary diagnosis and patients with a 
Fig. 2  The process model based on Drieschner and Boomsma 
(2008b). Note The figure represents models 1b/2b. The dotted lines 
(indicated by *) represent regression estimates that were added in a 
second version to create models 1c/2c, in which psychosocial func-
tioning and quality of life were also determined by suitability of treat-
ment and external pressure directly. The figure depicts latent vari-
ables, the observed variables and accompanying measurement errors 
underlying the latent variables were left out to avoid a cluttered pres-
entation
Fig. 3  Testing the obtained process model for IM across time on clin-
ical outcomes. Note The figure represents Model 3a, with all regres-
sion coefficients left unconstrained for the corresponding measure-
ments at baseline and follow-up (i.e. indicating that these are variant 
across time). Numbers represent standardized regression coefficients 
for the corresponding path (baseline / follow-up). Thick lines rep-
resent regression paths, dotted lines represent intercorrelations of 
variables. Boldface indicates statistical significance at P < 0.05 (two-
tailed). The figure depicts latent variables, the observed variables and 
accompanying measurement errors underlying the latent variables 
were left out to avoid a cluttered presentation
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primary diagnosis of a personality disorder. First, it was 
tested whether this model at baseline (Model 1f) was invari-
ant across patient groups by evaluating the χ2-difference 
test, which compared the model with all corresponding 
regression estimates constrained to be equal for the two 
patient groups (Model 4b) to the model where all regres-
sion estimates were unconstrained for the two patient groups 
(Model 4a). Table 4 shows the results for this comparison 
and it can be seen that the χ2-test did not reach statisti-
cal significance (Δχ2 = 17.57, Δdf = 15, P = 0.29), which 
provided support for the hypothesis that the IM model was 
invariant across these different patient groups at the baseline 
measurement.
The same procedure was repeated for the IM process 
model at follow-up. Here, it was found that the χ2-test for 
nested models did reach statistical significance (Δχ2 = 38.00, 
Δdf = 15, P < 0.01), which was interpreted as the IM pro-
cess model being not invariant across the patient groups at 
follow-up. That is, although the two patient groups could be 
described by a similar structural model at baseline (i.e. the 
regression coefficients between variables in the model at 
baseline were not significantly different between the groups), 
this was not the case for the follow-up assessment. Further 
testing of differences between patient groups with models 
that included both time points simultaneously also showed 
that the two patient groups were not invariant. In sum, these 
tests of the obtained IM process model suggest that this 
model is not stable across time nor across patient groups.
Variance explained and predictive value of the IM process 
model
It can be seen in Table 5 that the obtained IM process 
model explained between 22 and 86% of treatment engage-
ment, between 38 and 43% of psychosocial functioning and 
between 31 and 42% of quality of life, depending on the 
timing of the assessment.
Discussion
Key findings and interpretation
Regarding the first objective, the hypothesized mediational 
effect of motivation for engaging in treatment between 
internal determinants and treatment engagement was only 
partially supported. A mediation effect was only found for 
Table 4  Model comparisons to test for robustness of the obtained model across time and patient groups
C or U Model with either constrained (C) or unconstrained (U) regression coefficients for corresponding measurements at baseline and follow-
up. The constrained (nested) model is the more constrictive model with more degrees of freedom than the comparison model. The grey and 
white shading indicates models that are rivalling (nested) models (similar shading indicates rivaling models)
χ2 Chi square statistic, df degrees of freedom, Δ χ2 Chi square value of the MLR difference test, Δ df difference in degrees of freedom between 
the models being compared
Model C or U χ2 df χ2/ df Δ Χ2 Δ df Δ Χ2/Δ df P value Interpretation based on statistical 
inference
3a. Baseline and follow-up jointly 
(as 1f and 2f)
U 244.94 86 2.85 247.47 15 16.50 < 0.01 The model is variant across time
3b. Baseline and follow-up jointly 
(as 1f and 2f)
C 589.39 101 5.84
4a. Baseline process model (as 1f) 
for psychotic versus personality 
disorders
U 31.11 28 1.11 17.57 15 1.17 0.29 The model is invariant across patient 
groups at baseline
4b. Baseline process model (as 1f) 
for psychotic versus personality 
disorders
C 48.92 43 1.13
5a Follow-up process model (as 2f) 
for psychotic versus personality 
disorders
U 50.67 28 1.81 38.00 15 2.53 < 0.01 The model is variant across patient 
groups at follow-up
5b Follow-up process model (as 2f) 
for psychotic versus personality 
disorders
C 87.25 43 2.03
Table 5  Variances explained by the IM process model
MET Motivation to engage in treatment, TE treatment engagement, 
PF Psychosocial functioning, QL quality of life, N.a. not applicable. 
Boldface indicates P < 0.05 (two-tailed)
Model Variance  (R2)
MET TE PF QL
1. Baseline 0.44 0.22 0.38 0.42
2. Follow-up 0.73 0.86 0.43 0.31
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the variables perceived problem recognition, perceived 
suitability of treatment, perceived costs of treatment and 
perceived outcome expectancy, whose effects on treatment 
engagement were mediated by motivation for treatment (see 
Fig. 3). However, no such full mediation effect was found 
for distress and perceived external pressure. The model 
did not show a good model fit until additional direct paths 
between distress and all clinical outcomes were incorpo-
rated. Perceived external pressure was found to be of direct 
influence on the patient’s treatment engagement, independ-
ent of a mediational effect by motivation. Thus, the final 
structural model was neither in line with original hypoth-
esized theory as shown in Fig. 1 nor was it similar to the 
obtained empirical model which was previously found by 
Drieschner and Boomsma in a forensic psychiatric research 
population (2008b), in which the patient’s motivation for 
engaging in treatment also mediated the relation between 
problem recognition and treatment engagement (whereas we 
found no effect of problem recognition on any of the out-
comes) and which showed that suitability of treatment was 
directly related to treatment engagement (whereas we found 
a mediational effect) and showed no effect of perceived costs 
of treatment (whereas we did).
Regarding the second objective, the obtained plausible 
model was not stable across time nor across different patient 
groups. These findings indicate that this theory in its current 
form does not constitute a robust framework for patterns 
through which patients become motivated to engage in treat-
ment. On the one hand, it is not surprising that the identified 
model differs between patients with psychotic disorders and 
personality disorders, or that this is different for forensic 
psychiatric outpatients compared to outpatients with severe 
mental illness (with or without a history of offending). On 
the other hand, it would have strengthened the utility and 
generalizability of the theory if similar patterns of associa-
tions between motivational variables would appear across 
time and across different patient populations. Future studies 
should aim to replicate the current study in other populations 
and aim to explain (if and) why these differences occur. In 
addition, since the patient’s quality of life and psychoso-
cial functioning are of great interest to treatment outcomes, 
future studies may aim to explore subdomains within these 
outcomes and how this affects the fit of the model.
Despite these findings regarding the structure and stabil-
ity of the IM, the current study does provide insight into 
which factors are most relevant for the patient’s motivation 
and treatment engagement. Both our work and that of Drie-
schner (2005) showed that perceived suitability of treatment 
and outcome expectancy were most strongly associated with 
motivation and treatment engagement. These determinants 
comprise the patient’s perception of the treatment and rela-
tionship with the clinician, and the perceived competence in 
being able to do what the treatment requires, and the findings 
underscore their importance in relation to motivation and 
treatment outcomes.
Further, the level of distress is generally regarded an 
important determinant of treatment motivation, such that 
more (symptomatic) suffering makes patients more moti-
vated to engage in treatment (Angst et al. 2010). Indeed, 
studies have found that treatment-seeking patients with per-
sonality disorders or substance-use disorders reported higher 
subjective distress than those who did not seek treatment 
(van Beek and Verheul 2008; Velasquez et al. 2000). How-
ever, others have found a so-called ‘motivation paradox’ in 
patients with SMI, such that those with more symptoms and 
more psychosocial problems are less motivated for engaging 
in treatment (Mulder et al. 2014). This latter observation 
is consistent with the current study, where distress showed 
a negative association with treatment engagement and was 
unrelated to motivation for engaging in treatment (control-
ling for the other internal determinants). Drieschner and 
Boomsma found similar results in their studies in forensic 
psychiatric patients (2008b). This implies that, higher dis-
tress may withhold outpatients with SMI from in engag-
ing with treatment, which may be related to the finding 
that higher distress is also associated with lower outcome 
expectancy and lower perceived suitability of treatment (see 
Table 2). For patients where distress is high and other moti-
vational determinants are low, this may provide an argument 
for the paternalistic practices as performed by the assertive 
outreach teams, trying to engage patients who might other-
wise be left untreated (Mulder et al. 2014). These patients 
might be engaged by first increasing the external (legal) 
pressure, as – again similar to the findings of Drieschner 
and Boomsma (2008b) - we found that perceived external 
(legal) pressure was directly related to treatment engage-
ment, whereas no significant association between external 
pressure and motivation was found. These findings suggest 
that patients may engage in treatment due to external pres-
sures, regardless of how motivated they are (by themselves). 
Alternatively, this finding may relate to the assessment of 
treatment engagement with the SES. It has been noted that 
the items in the SES do not constitute a complete measure 
of engagement that represents all efforts clients make dur-
ing the course of treatment, but only reflect those that are 
observed by clinicians within and surrounding sessions, not 
those between sessions or the view of patients themselves 
(Holdsworth et al. 2014). The authors of the SES acknowl-
edge that there may be an element of coercion in asking 
clients to engage with treatment services (Tait et al. 2002), 
which is also reflected in the operationalization of treatment 
engagement in the SES, and this may explain why exter-
nal pressure as perceived by patients is related to treatment 
engagement and not to self-reported motivation in our study.
Regarding the differences between the structural models 
at the two time points, it seems remarkable that not only the 
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strengths of the relationships between the IDs and motiva-
tion were different, but also—in some cases—the direction 
of these relationships. For example, the correlation between 
perceived suitability of treatment and motivation was posi-
tive (see Table 2), but when corrected for the influence of the 
other internal determinants resulted in a negative association 
at baseline, and again a positive association at follow-up (see 
Fig. 2). After ruling out the possibility of multicollinearity 
problems, we interpreted this finding as valid and indicat-
ing that the interrelations of the internal determinants are 
more complex than the current theory suggests. This should 
therefore be subject of subsequent investigations of the IM.
Thirdly and finally, the obtained plausible model was 
able to explain substantial amounts of variance in treat-
ment engagement, psychosocial functioning and quality of 
life. The model explained between 22 and 86% of treatment 
engagement, between 38 and 43% of psychosocial function-
ing and between 31 and 42% of quality of life, depending 
on the timing of the assessment. The discrepancy between 
explained variances at baseline and at follow-up may be 
explained by the relative contributions of perceived suit-
ability of treatment and motivation, which were more pro-
nounced at the follow-up assessment. All in all, this suggests 
that the concepts contained within the IM hold potential to 
predict treatment outcomes, which warrants further empiri-
cal investigation into the IM.
Strengths and limitations
Strengths of the current study include the longitudinal com-
ponent which allowed for testing of the model at two time 
points, a relatively large sample size considering the often 
difficult to engage patient population, that it was a multi-
center study, the correction for unreliability of measure-
ments and testing of rivalling models.
Limiting the current study is the possibility of model 
misspecification, which should not be underestimated. 
Misspecification of the model may have occurred due 
to misspecification of the relations between the internal 
determinants or if some of the relations in the model were 
actually bidirectional (such as between distress and psy-
chosocial functioning and quality of life). These alterna-
tives were not tested as these were not in line with IM, 
but the idea of reciprocal relationships between some of 
the variables in the model is actually possible. For exam-
ple, not only may motivation for engaging with treatment 
depend on the patient’s outcome expectancy, but in turn 
the patient’s outcome expectancy may depend on (previ-
ous) motivation for engaging in treatment and previous 
treatment engagement behaviours. Such relations are likely 
for ongoing, repeated behaviours (Weinstein 2007) as is 
the case in our study sample, where the mean age of first 
contact with mental health care was 26 (Jochems et al. 
2015). Further, although efforts were made to compare 
different structural models and to identify a model which 
was most plausible considering both theory and data, our 
final model was based on a backward elimination approach 
which opens the possibility of a ranking and selection 
problem. That is, the constriction of certain paths in the 
model to zero (i.e. “dropping them”), was based on this 
study sample which might not be generalizable to other 
samples let alone to the entire population of outpatients 
with SMI. Future studies should try to replicate our find-
ings in other samples and with more elaborate measures 
of treatment engagement, as engagement may differ across 
client groups and the differentiation between treatment 
engagement, treatment compliance and medication com-
pliance is relevant for a comprehensive understanding of 
the relationships between internal determinants, motiva-
tion and treatment engagement. Furthermore, future stud-
ies may also want to include means into model testing, to 
investigate whether these are different between different 
patient groups and over time.
It is considered a strength that our sample largely repre-
sents a broad population of outpatients with diagnoses of 
psychotic and personality disorders with a variety of co-
morbid psychiatric disorders, which strengthens the general-
izability of the study. However, patients with relatively high 
levels of motivation for treatment, treatment engagement and 
psychosocial functioning may still have been more likely to 
participate in and complete the study compared to patients 
with low motivation, low engagement and poor function-
ing. Therefore, the results may not be generalizable to the 
entire population of outpatients with SMI, in particular those 
patients who are not in contact with services. Future studies 
should further investigate the generalizability of the TMS-f 
and the TMS-p to other patient populations and nationali-
ties, as the scales and the conceptual framework of the IM 
may prove useful in the understanding and communication 
about motivation for engaging with treatment services in 
other mental health contexts as well.
Conclusion and implications
The current study showed that the relations between internal 
determinants, motivation for engaging in treatment, treat-
ment engagement and clinical outcomes were not consistent 
with the original theory, nor were they consistent across time 
and different patient diagnostic groups. Future studies should 
aim to test the IM in other clinical populations, to further 
specify the relations between constructs in the model and to 
re-specify (or reject) the initially hypothesized principles. 
Depending on the context of these future studies, researchers 
may choose to use the original TMS-f or the TMS-p. The 
IM might be improved by re-specifying the interrelations of 
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the internal determinants and/or by including intermediary 
factors such as action planning between the level of MET 
and the actual treatment engagement (Jochems et al. 2011; 
Sutton 2008). Including such intermediary factors might cre-
ate opportunities to beneficially influence the pathway to 
treatment engagement. The constructs in the model did show 
explanatory value, which demonstrates the future potential 
of IM (constructs) as a basis for interventions in the mental 
health care for outpatients with SMI. In further testing of the 
theory, it will become more accurate and thus more useful 
for application in clinical practice. Clinical implications of 
our findings include that perceived suitability of treatment, 
perceived costs of treatment and outcome expectancy cur-
rently seem the most interesting targets for interventions 
aimed at improving motivation and treatment engagement.
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